We appreciate and would like to respond to the comments submitted by Grey et al. Their first concern is a lack of randomized trial data reporting beneficial extraskeletal effects of vitamin D supplementation for an array of chronic diseases. We agree and do not recommend vitamin D supplementation to treat any of the diseases that they mention. However, the following 3 studies conducted within the past few years support the extraskeletal benefits of vitamin D supplementation. (1) The 4-year, randomized, double-blind, placebo-controlled trial by Lappe et al1 involving 1179 community-dwelling postmenopausal women in which calcium supplementation (consisting of either calcium citrate [1400 mg/d] or calcium carbonate [1500 mg/d]) was compared with calcium plus 1100 IU/d of cholecalciferol (vitamin D3). There was a significantly lower cancer rate in the calcium plus vitamin D group (relative risk [RR], 0.232; P < .005).1 (2) El-Hajj and colleagues2 treated 179 girls aged 10 to 17 years with the equivalent of either 200 IU or 2000 IU/d of vitamin D3 preparation over 1 year in a double-blind, placebo-controlled trial. They demonstrated a significant increase in lean muscle mass in both groups (P < .05). (3) Broe and colleagues3 treated nursing home residents with 800 IU/d of vitamin D2 and demonstrated a 72% lower adjusted-incidence rate ratio of falls, compared with those residents who received lower doses of vitamin D and for whom no benefit was seen.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.